Ocular

RSS

KeraVision Ring evaluated in extended phase III trial

Nov. 21, 1997

Promising phase III results reported for KeraVision ring

Nov. 4, 1997

German launch for Xalatan

Oct. 23, 1997

Patient recruitment for verteporfin phase III trials exceeds goals

Sep. 30, 1997

Lotemax deemed approvable by FDA

Sep. 26, 1997

Angiogenesis inhibitors described by Janssen

Sep. 25, 1997

AEterna initiates phase I trial in AMD

Sep. 24, 1997

Axokine use in retinal degeneration covered in new patent

Sep. 23, 1997

Initial phase III results reported for KeraVision Ring

Sep. 17, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997